APA (7th ed.) Citation

Churdboonchart, V., Sakondhavat, C., Kulpradist, S., Ayudthya, B. I. N., Chandeying, V., Rugpao, S., . . . Moss, R. (2001). A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300. Clinical and diagnostic laboratory immunology, 8(6), 1295. https://doi.org/10.1128/CDLI.8.6.1295-1295.2001

Chicago Style (17th ed.) Citation

Churdboonchart, V., et al. "A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300." Clinical and Diagnostic Laboratory Immunology 8, no. 6 (2001): 1295. https://doi.org/10.1128/CDLI.8.6.1295-1295.2001.

MLA (9th ed.) Citation

Churdboonchart, V., et al. "A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300." Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 6, 2001, p. 1295, https://doi.org/10.1128/CDLI.8.6.1295-1295.2001.